Literature DB >> 21361889

Bayesian design of noninferiority trials for medical devices using historical data.

Ming-Hui Chen1, Joseph G Ibrahim, Peter Lam, Alan Yu, Yuanye Zhang.   

Abstract

We develop a new Bayesian approach of sample size determination (SSD) for the design of noninferiority clinical trials. We extend the fitting and sampling priors of Wang and Gelfand (2002, Statistical Science 17, 193-208) to Bayesian SSD with a focus on controlling the type I error and power. Historical data are incorporated via a hierarchical modeling approach as well as the power prior approach of Ibrahim and Chen (2000, Statistical Science 15, 46-60). Various properties of the proposed Bayesian SSD methodology are examined and a simulation-based computational algorithm is developed. The proposed methodology is applied to the design of a noninferiority medical device clinical trial with historical data from previous trials.
© 2011, The International Biometric Society.

Entities:  

Mesh:

Year:  2011        PMID: 21361889      PMCID: PMC3136555          DOI: 10.1111/j.1541-0420.2011.01561.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  13 in total

1.  Bayesian design and analysis of active control clinical trials.

Authors:  R Simon
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

2.  Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.

Authors:  Ralph B D'Agostino; Joseph M Massaro; Lisa M Sullivan
Journal:  Stat Med       Date:  2003-01-30       Impact factor: 2.373

3.  Design and analysis of non-inferiority mortality trials in oncology.

Authors:  Mark Rothmann; Ning Li; Gang Chen; George Y H Chi; Robert Temple; Hsiao-Hui Tsou
Journal:  Stat Med       Date:  2003-01-30       Impact factor: 2.373

4.  Some fundamental issues with non-inferiority testing in active controlled trials.

Authors:  H M James Hung; Sue-Jane Wang; Yi Tsong; John Lawrence; Robert T O'Neil
Journal:  Stat Med       Date:  2003-01-30       Impact factor: 2.373

5.  Planning and analysis of three-arm non-inferiority trials with binary endpoints.

Authors:  Meinhard Kieser; Tim Friede
Journal:  Stat Med       Date:  2007-01-30       Impact factor: 2.373

Review 6.  A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trials.

Authors:  H M James Hung; Sue-Jane Wang; Robert O'Neill
Journal:  Biom J       Date:  2005-02       Impact factor: 2.207

7.  Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials.

Authors:  Brian P Hobbs; Bradley P Carlin; Sumithra J Mandrekar; Daniel J Sargent
Journal:  Biometrics       Date:  2011-03-01       Impact factor: 2.571

8.  Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.

Authors:  Gregg W Stone; Stephen G Ellis; Louis Cannon; J Tift Mann; Joel D Greenberg; Douglas Spriggs; Charles D O'Shaughnessy; Samuel DeMaio; Patrick Hall; Jeffrey J Popma; Joerg Koglin; Mary E Russell
Journal:  JAMA       Date:  2005-09-14       Impact factor: 56.272

9.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

Authors:  Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

10.  A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: design and statistical methods of the PERSEUS clinical program.

Authors:  Dominic J Allocco; Louis A Cannon; Amy Britt; John E Heil; Andrey Nersesov; Scott Wehrenberg; Keith D Dawkins; Dean J Kereiakes
Journal:  Trials       Date:  2010-01-07       Impact factor: 2.279

View more
  17 in total

1.  Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes.

Authors:  Joseph G Ibrahim; Ming-Hui Chen; H Amy Xia; Thomas Liu
Journal:  Biometrics       Date:  2011-09-28       Impact factor: 2.571

2.  Bayesian hierarchical modeling based on multisource exchangeability.

Authors:  Alexander M Kaizer; Joseph S Koopmeiners; Brian P Hobbs
Journal:  Biostatistics       Date:  2018-04-01       Impact factor: 5.899

3.  Bayesian clinical trial design using historical data that inform the treatment effect.

Authors:  Matthew A Psioda; Joseph G Ibrahim
Journal:  Biostatistics       Date:  2019-07-01       Impact factor: 5.899

4.  Bayesian design of biosimilars clinical programs involving multiple therapeutic indications.

Authors:  Matthew A Psioda; Kuolung Hu; Yang Zhang; Jean Pan; Joseph G Ibrahim
Journal:  Biometrics       Date:  2019-11-11       Impact factor: 2.571

5.  Bayesian probability of success for clinical trials using historical data.

Authors:  Joseph G Ibrahim; Ming-Hui Chen; Mani Lakshminarayanan; Guanghan F Liu; Joseph F Heyse
Journal:  Stat Med       Date:  2014-10-23       Impact factor: 2.373

6.  Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome.

Authors:  Ming-Hui Chen; Joseph G Ibrahim; Donglin Zeng; Kuolung Hu; Catherine Jia
Journal:  Biometrics       Date:  2014-07-16       Impact factor: 2.571

Review 7.  Use of historical control data for assessing treatment effects in clinical trials.

Authors:  Kert Viele; Scott Berry; Beat Neuenschwander; Billy Amzal; Fang Chen; Nathan Enas; Brian Hobbs; Joseph G Ibrahim; Nelson Kinnersley; Stacy Lindborg; Sandrine Micallef; Satrajit Roychoudhury; Laura Thompson
Journal:  Pharm Stat       Date:  2013-08-05       Impact factor: 1.894

8.  Bayesian sequential meta-analysis design in evaluating cardiovascular risk in a new antidiabetic drug development program.

Authors:  Ming-Hui Chen; Joseph G Ibrahim; H Amy Xia; Thomas Liu; Violeta Hennessey
Journal:  Stat Med       Date:  2013-12-16       Impact factor: 2.373

9.  Bayesian Design of Non-Inferiority Clinical Trials via the Bayes Factor.

Authors:  Wenqing Li; Ming-Hui Chen; Xiaojing Wangy; Dipak K Dey
Journal:  Stat Biosci       Date:  2017-07-06

10.  The power prior: theory and applications.

Authors:  Joseph G Ibrahim; Ming-Hui Chen; Yeongjin Gwon; Fang Chen
Journal:  Stat Med       Date:  2015-09-07       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.